A phase II clinical trial has found that a combination of three drugs — interferon beta-1b, lopinavir-ritonavir, and ribavirin — plus standard care is successful in treating mild-to-moderate cases of COVID-19.
Yes decided to come back after the crash, but promised myself would go too deep, most my cash in funds these days, hold tils and sng, this caught my eye at £1m mkt cap, high growth stock about to turn profitable soon.